Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimo Dietrich

Showing results (41-50 of 116) with videos related to

Pageof 12
Sort By:
Clinical Colorectal Cancer|March 28, 2018
Significance of PITX2 Promoter Methylation in Colorectal Carcinoma PrognosisAlexander Semaan, Barbara Uhl, Vittorio Branchi, et al.
Tissue Engineering and Regenerative Medicine|January 30, 2021
TNF-α-Inhibition Improves the Biocompatibility of Porous Polyethylene Implants In VivoTimon Hussain, Donata Gellrich, Svenja Siemer, et al.
Clinical Genitourinary Cancer|January 9, 2017
Systematic Expression Analysis of Mitochondrial Complex I Identifies NDUFS1 as a Biomarker in Clear-Cell Renal-Cell CarcinomaJörg Ellinger, Mirjam Poss, Maria Brüggemann, et al.
Oncotarget|November 16, 2016
Systematic expression analysis of the mitochondrial complex III subunits identifies UQCRC1 as biomarker in clear cell renal cell carcinomaJörg Ellinger, Arabella Gromes, Mirjam Poss, et al.
Molecular Cancer Research : MCR|April 8, 2016
SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in Prostate Cancer CellsFlorian Handle, Holger H H Erb, Birgit Luef, et al.
BMC Cancer|August 16, 2019
Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinomaMadeleine Sassenberg, Johanna Droop, Wolfgang A Schulz, et al.
Virchows Archiv : an International Journal of Pathology|December 4, 2016
CXCL12 expression and PD-L1 expression serve as prognostic biomarkers in HCC and are induced by hypoxiaAlexander Semaan, Dimo Dietrich, Dominik Bergheim, et al.
Epigenetics|April 14, 2020
The landscape of <i>CD28, CD80, CD86, CTLA4</i>, and <i>ICOS</i> DNA methylation in head and neck squamous cell carcinomasLuka de Vos, Ingela Grünwald, Emma Grace Bawden, et al.
Biotechniques|October 27, 2009
A novel method for sensitive and specific detection of DNA methylation biomarkers based on DNA restriction during PCR cyclingChristoph Kneip, Bernd Schmidt, Michael Fleischhacker, et al.
Epigenetics|October 1, 2016
CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patientsSebastian Meller, Lisa Zipfel, Heidrun Gevensleben, et al.
Pageof 12

Showing results (41-50 of 116) with videos related to

Sort By:
Pageof 12
Clinical Colorectal Cancer|March 28, 2018
Significance of PITX2 Promoter Methylation in Colorectal Carcinoma PrognosisAlexander Semaan, Barbara Uhl, Vittorio Branchi, et al.
Tissue Engineering and Regenerative Medicine|January 30, 2021
TNF-α-Inhibition Improves the Biocompatibility of Porous Polyethylene Implants In VivoTimon Hussain, Donata Gellrich, Svenja Siemer, et al.
Clinical Genitourinary Cancer|January 9, 2017
Systematic Expression Analysis of Mitochondrial Complex I Identifies NDUFS1 as a Biomarker in Clear-Cell Renal-Cell CarcinomaJörg Ellinger, Mirjam Poss, Maria Brüggemann, et al.
Oncotarget|November 16, 2016
Systematic expression analysis of the mitochondrial complex III subunits identifies UQCRC1 as biomarker in clear cell renal cell carcinomaJörg Ellinger, Arabella Gromes, Mirjam Poss, et al.
Molecular Cancer Research : MCR|April 8, 2016
SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in Prostate Cancer CellsFlorian Handle, Holger H H Erb, Birgit Luef, et al.
BMC Cancer|August 16, 2019
Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinomaMadeleine Sassenberg, Johanna Droop, Wolfgang A Schulz, et al.
Virchows Archiv : an International Journal of Pathology|December 4, 2016
CXCL12 expression and PD-L1 expression serve as prognostic biomarkers in HCC and are induced by hypoxiaAlexander Semaan, Dimo Dietrich, Dominik Bergheim, et al.
Epigenetics|April 14, 2020
The landscape of <i>CD28, CD80, CD86, CTLA4</i>, and <i>ICOS</i> DNA methylation in head and neck squamous cell carcinomasLuka de Vos, Ingela Grünwald, Emma Grace Bawden, et al.
Biotechniques|October 27, 2009
A novel method for sensitive and specific detection of DNA methylation biomarkers based on DNA restriction during PCR cyclingChristoph Kneip, Bernd Schmidt, Michael Fleischhacker, et al.
Epigenetics|October 1, 2016
CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patientsSebastian Meller, Lisa Zipfel, Heidrun Gevensleben, et al.
Pageof 12